Incidence of Pregnancy-Associated Cancer in Two Canadian Provinces: A Population-Based Study.

cancer incidence rate data linkage epidemiology novel use of cancer registry obstetrics pregnancy pregnancy-associated cancer temporal trends

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
17 03 2021
Historique:
received: 30 01 2021
revised: 11 03 2021
accepted: 15 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 27 4 2021
Statut: epublish

Résumé

Pregnancy-associated cancer-that is diagnosed in pregnancy or within 365 days after delivery-is increasingly common as cancer therapy evolves and survivorship increases. This study assessed the incidence and temporal trends of pregnancy-associated cancer in Alberta and Ontario-together accounting for 50% of Canada's entire population. Linked data from the two provincial cancer registries and health administrative data were used to ascertain new diagnoses of cancer, livebirths, stillbirths and induced abortions among women aged 18-50 years, from 2003 to 2015. The annual crude incidence rate (IR) was calculated as the number of women with a pregnancy-associated cancer per 100,000 deliveries. A nonparametric test for trend assessed for any temporal trends. In Alberta, the crude IR of pregnancy-associated cancer was 156.2 per 100,000 deliveries (95% CI 145.8-166.7), and in Ontario, the IR was 149.4 per 100,000 deliveries (95% CI 143.3-155.4). While no statistically significant temporal trend in the IR of pregnancy-associated cancer was seen in Alberta, there was a rise in Ontario (

Identifiants

pubmed: 33802896
pii: ijerph18063100
doi: 10.3390/ijerph18063100
pmc: PMC8002657
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : MY2-155363
Pays : Canada

Références

CMAJ. 2019 Nov 18;191(46):E1262-E1273
pubmed: 31740536
Lung Cancer. 2013 Dec;82(3):499-505
pubmed: 24091171
BMC Health Serv Res. 2016 Jul 12;16:255
pubmed: 27406214
Cancer Res. 2020 May 1;80(9):1790-1798
pubmed: 32075799
Stat Med. 1985 Jan-Mar;4(1):87-90
pubmed: 3992076
CMAJ. 2016 Jun 14;188(9):E181-E190
pubmed: 27067818
Curr Oncol. 2019 Aug;26(4):228-233
pubmed: 31548801
Eur J Obstet Gynecol Reprod Biol X. 2019 May 12;3:100025
pubmed: 31404420
Obstet Gynecol. 2013 Sep;122(3):608-17
pubmed: 23921869
BJOG. 2012 Dec;119(13):1572-82
pubmed: 22947229
Int J Gynecol Cancer. 2017 Mar;27(3):613-619
pubmed: 28107260
Clin Transl Oncol. 2014 Feb;16(2):122-7
pubmed: 24002946
J Womens Health (Larchmt). 2019 Feb;28(2):250-257
pubmed: 30307780

Auteurs

Amy Metcalfe (A)

Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Department of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.

Zoe F Cairncross (ZF)

Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB T2N 1N4, Canada.

Christine M Friedenreich (CM)

Department of Community Health Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.
Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, AB T2S 3C3, Canada.

Joel G Ray (JG)

Department of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON M5S 1A1, Canada.
SickKids Research Institute, Toronto, ON M5G 0A4, Canada.

Gregg Nelson (G)

Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB T2N 1N4, Canada.

Deshayne B Fell (DB)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 5B2, Canada.

Sarka Lisonkova (S)

Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Parveen Bhatti (P)

Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1G1, Canada.

Carly McMorris (C)

Werkland School of Education, University of Calgary, Calgary, AB T2N 1N4, Canada.

Khokan C Sikdar (KC)

Department of Community Health Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.
Alberta Health Services, Calgary, AB T5J 3E4, Canada.

Lorraine Shack (L)

Department of Community Health Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.
Department of Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada.
Cancer Research and Analytics, Cancer Control Alberta, Alberta Health Services, Calgary, AB T5J 3E4, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH